chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Flu like symptoms; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A male patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: INFLUENZA LIKE ILLNESS (non-serious), outcome "unknown", described as "Flu like symptoms".  Additional information: Concomitant: There is no concomitant list. Patient also reported that people who go the Pfizer first shot felt flu like symptoms also. Treatment: unknown. Product Complaint: There is no product complaint associated with this case.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
THROMBOCYTOPENA- Platelet count usually 170K   1/8  covid vaccine #1             1/12     platelet count 15k                                             1/14             "           10k                                         Given high dose dexamethasone 1/29  covid                                 1/25 platelets       46k          vaccine #2            2/2 paltelets 4k                   again given high dose dexamethasone 2/9 platelets 184k                           2/16 platelets 85k
Pain at injection site, decreased range of motion. During the diabetic check up on 10/17, patient mentioned this to the doctor.  Doctor said it could be SIRVA.  Patient is starting PT.
This case was reported by a healthcare professional and described the occurrence of 20 cm by 20 cm swollen area at injection site in a 5-year-old male subject who was vaccinated with diphtheria and tetanus toxoids and acellular pertussis vaccine adsorbed (Infanrix, GlaxoSmithKline) for prophylaxis. Previous and/or concurrent vaccination included live attenuated measles, mumps (strain not specified), rubella vaccine; Merck given on 17 July 2006; live attenuated oral poliomyelitis vaccine; Aventis Pasteur given on 17 July 2006. The subject had no relevant medical history. The subject's concurrent medications were not provided. The subject had no adverse events following previous vaccinations. On 17 July 2006, the subject received the 5th dose of Infanrix (lot number AC14B036AA, intramuscular, left thigh). At an unspecified time after vaccination with Infanrix, the subject experienced injection site redness and warm to touch injection site. On 19 July 2006, the subject developed 20 cm by 20 cm swollen area at the injection site. The subject was prescribed diphenhydramine hydrochloride (Benadryl), ice and ibuprofen (Motrin). At the time of reporting, the events were resolved. The attenuated measles, mumps (strain not specified), rubella vaccine and live attenuated oral poliomyelitis vaccine injection sites did not have the same reaction as the Infanrix injection site.
Development of painful swelling in the left upper arm, gradually worsening and increasing in size subsequently diagnosed as subcutaneous panniculitis -like T-cell lymphoma
tonic clonic seizure - lab results showed an otherwise unexplained decrease in serum lamotrigine level - immune response/metabolism of vaccine likely caused decrease in serum lamotrigine, which likely led to the seizure. no other changes in medications, daily activity, diet, etc. to explain decreased lamotrigine serum level.
Local reaction - erythematous papules on both thighs at site of injection slightly raised; occurred within 24 hr of vaccines.
a few sore arms; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  An elderly male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), as dose number (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (dose 1), for COVID-19 Immunization; Bnt162b2 (dose 2), for COVID-19 Immunization; Bnt162b2 (dose 3), for COVID-19 Immunization. The following information was reported: PAIN IN EXTREMITY (non-serious), outcome "unknown", described as "a few sore arms".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-PV202300149591 same patient/event/vaccine; different dose;
redness is getting bigger; is actually very swollen; it's uncomfortable; it's really really hot; it got red; it was kind of swelling; arm was a little hurting; there was some discomfort; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm was a little hurting), DISCOMFORT (there was some discomfort), ERYTHEMA (it got red), SWELLING (it was kind of swelling) and ERYTHEMA (redness is getting bigger) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for an unknown indication. The occurrence of additional non-serious events is detailed below.     no medical history was reported.  Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID) and ERGOCALCIFEROL, RETINOL PALMITATE (VITAMINS A & D) for an unknown indication.    On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Feb-2021, the patient experienced PAIN IN EXTREMITY (arm was a little hurting) and DISCOMFORT (there was some discomfort). On 18-Feb-2021, the patient experienced ERYTHEMA (it got red), SWELLING (it was kind of swelling) and DRY SKIN (it's really really hot). On 19-Feb-2021, the patient experienced ERYTHEMA (redness is getting bigger), PERIPHERAL SWELLING (is actually very swollen) and FEELING ABNORMAL (it's uncomfortable). On 13-Feb-2021, PAIN IN EXTREMITY (arm was a little hurting) and DISCOMFORT (there was some discomfort) had resolved. At the time of the report, ERYTHEMA (it got red), SWELLING (it was kind of swelling), ERYTHEMA (redness is getting bigger), PERIPHERAL SWELLING (is actually very swollen), FEELING ABNORMAL (it's uncomfortable) and DRY SKIN (it's really really hot) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.    Treatment details included None.
Our pharmacy mistakenly scheduled the patient for his second Moderna dose for 6/14/21, only three weeks after he received his first dose on 05/24/21, and he received the second dose on 6/14/21. The error was discovered on 6/16/21, and I spoke with the patient to notify him of our error. He said he has not had any adverse effects and is currently feeling fine. I asked him to notify our pharmacy if he has any adverse effects, and I provided him with the VAERS telephone number to use if needed.
Information has been received from a physician concerning an adult pt who was vaccinated with a first and second dose of varicella virus vaccine live. Subsequently, the pt had no detectable antibodies. Additional information has been requested.
Patient was given the undiluted pediatric does of Pfizer when it should have been the adult dose
This spontaneous report was received from a Registered Nurse (R.N) concerning multiple unspecified patients of unknown age and gender. The patients' pertinent medical history and concurrent conditions were not reported. On an unknown date, the patients were vaccinated with improperly stored doses of PROQUAD (Lot # N010247; expiration date 25-SEP-2018) for prophylaxis (dose and route not reported). It was also reported that the vaccine was reconstituted with properly stored diluent (Lot # unknown by reporter). The temperature was -14°C to -10°C for 257 hours and there was no previous temperature excursion. The call was made because of a data logger. Adverse effects reported and there was no PQC involved. This is one of several cases from the same source.; Sender's Comments: US-009507513-1708USA003628: US-009507513-1708USA003629: US-009507513-1708USA003635: US-009507513-1708USA003631: US-009507513-1708USA003632: US-009507513-1708USA011937: US-009507513-1708USA003634: US-009507513-1708USA003627: US-009507513-1708USA003630:
Have a history of periodic rectal bleeding (blood clots) since 2008 - every six weeks has rectal bleeding.  Three weeks after vaccine, hives at vaccine site.  Four weeks after vaccination, had arm/neck vein swelling, and increase in episodes of rectal bleeding with pain.
pt recv vax 15OCT97 & 2 days later pt exp a local rxn @ the inj site described as red, swollen, indurated, hard, hot to touch & painful;
Information has been received from a physician concerning a 6 year old female who was vaccinated a couple of years before with varicella virus vaccine live. Subsequently, the patient came to the office with a mild chicken pox rash, fever, and less than fifty lesions. There was no product quality complaint involved. The reporter also indicated that patient's sister (WAES0405USA00652) and another male patient (WAES0403USA02431) had similar experiences following exposure to varicella virus vaccine live. Additional information has been requested.
2 hours after injection, pt felt weakness, dizziness and heart palpitations. Pt also felt like he had heart burn in his chest and abdomen. Pt laid down and felt like he was going to pass out. Symptoms lasted 45 min. Burning sensation lasted a full day and night.
Patient admitted to hospital with stroke like symptoms, right side facial droop, no other s/s associated with stroke. Patient worked up for Bell's palsy. Patient began having symptoms around 1700 on 6/6/21 and arrived at ED late that evening
Woke up on 2/4/2021 with aches, headache, nausea and chills.  Lasted 24 hours. later in the evening she took Tylenol because she felt nauseous all day.
Vaccine administered on 9/30/11. She called in on 10/7/11 complaining of arm pain at site. She came back in on 11/2/11 for labs, she again complained of pain at the site of injection. The pain worsens with abduction of the arm. Pt. advised to take NSAIDS and use warm compresses.
Patient received Pfizer Covid Vaccine 5-11 on 01/19/22, patient is not 5 years old. Patient is healthy and had no reactions. Parents are aware of the incidents.
patient passed out almost 7 minutes after getting the vaccine and she woke up within a moment.
The patient went to an urgent care clinic on 8-7-21 complaining of nausea and abdominal pain radiating to the chest. She was treated with omeprazole. The patient then came to her pediatrician's office on 8-9-21 with continued abdominal pain. She had blood work done that included an elevated BUN and creatinine The patient was then admitted on 8-10-21 through 8-16-2021 with diagnosis including acute cholecystitis, acute kidney injury most likely from ATN, abnormal D-Dimer without pulmonary embolism or DVT, splenomegaly, acute respiratory failure with hypoxia, pneumonia, hyperkalemia and metabolic acidosis. She was discharged on antibiotics. She then presented to the pediatrician's office for hospital follow up and complained of chest pain and shortness of breath at night. She also reported hypoxia at night. The patient was then readmitted on 8-24 and remains in the hospital. Diagnosis include bilateral pleural effusions and pneumonia.
Patient was give moderna vaccine as the first dose on 9/23. After the shot, patient experienced arm pain and what he described as a pin point pain in his chest that went away in about 15 minutes, but them he said he felt dizzy and numbness and tingling in his arm that went up to his neck.
Redness,swelling and tightness at injection site warm to the touch, Fever of 100 and achiness.
I had an allergic reaction within an hour after vaccine with itching and broke out in hives all over. I took Benadryl and that did help relieved the hives within 3 hours and itching that helped immediately.
Patient with COVID vaccines who admitted to hospital with a COVID detected test.  Provider d/c note:  "86 YO male with h/o ESRD on HD (MWF), DMI, HTN who is presenting to the ED for evaluation of hypoxia noted at his residence earlier today. He had an O2 sat in the 40s per chart review and EMS was called. He had a non productive cough and shortness of breath a couple of days ago and had a home COVID test taken which was found to be positive. He was initially seen in medical and transferred to hospital due to having ESRD and being on 2L NC (initially on 4LNC). He states he has some shortness of breath and cough with clear to yellow colored sputum at times. He has not missed dialysis. Denied fevers, chills, nausea, vomiting.    Patient, though required supplemental oxygenation, was quickly weaned off and tolerating RA. He initially received decadron which was then stopped and home cortef was continued. Patient worked with therapy once symptom resolution occurred while receiving scheduled HD. Hospitalization was prolonged due to Covid recovery timeline required by rehabilitation. "
PATIENT WAS ADMINISTERD PFIZER VACCINE WHEN SHE SHOULD HAVE RECEIVE MODERNA VACCINE. PT IS 15 WEEKS PREGNANT.
Information was received fro a physician regarding a patient  who on 26-AUG-2008 received one dose of oral ROTATEQ (human-bovine) (lot# not reported), and spit it up. The patient was considered to be recovered on 26-AUG-2008. The patient sought medical attention while in the office. No product quality complaint was involved.  No further information is expected.
Feeling terrible; Feeling tired; Bloot clot in knee; A spontaneous report was received from a nurse who was a 72-year-old, female patient, who received Moderna's COVID-19 vaccine (mRNA-1273) and developed a blood clot in her knee, feeling terrible and feeling tired..   The patient's medical history was not provided by the reporter. No relevant concomitant medications were reported.  On 25 Feb 2021, the patient received her second of two planned doses of mRNA-1273 (Lot number: 031M20A) intramuscularly for prophylaxis of COVID-19 infection.   On 04 Mar 2021, a week after vaccination, the patient was seen at the hospital and was diagnosed with a blood clot in her knee of unknown origin.  She also reported that she has continued feeling terrible and feeling tired.  Lab details were not provided by the reporter.  Treatment for the events were unknown.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of the events, blood clot in her knee, feeling terrible and feeling tired, were considered unknown.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Pfizer COVID19 Vaccine received a week before Moderna booster; This spontaneous case was reported by a nurse and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Pfizer COVID19 Vaccine received a week before Moderna booster) in a 45-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 065F21A) for COVID-19 vaccination.     Previously administered products included for COVID-19 vaccination: PFIZER BIONTECH COVID-19 VACCINE (Patient had received Pfizer COVID19 Vaccine on 23-OCT-2021) on 23-Oct-2021. Past adverse reactions to the above products included No adverse event with PFIZER BIONTECH COVID-19 VACCINE.    On 06-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 06-Nov-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Pfizer COVID19 Vaccine received a week before Moderna booster). On 06-Nov-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Pfizer COVID19 Vaccine received a week before Moderna booster) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant information was reported. No treatment information was reported.
Immediately got hyper dehydrated. Then felt like I was going to passout soon. I ate a banana and drank pint of water. That helped   36 hours later my throught 1/2 of it, got very sore, like pins sticking inti it like a tonselitious maybe. Same time my mid/right side back started to hurt. Thought it might be gastral. Continious to this day and wordened up until today. Maybe Kidneys? or?? I was thinking again was gastral, but now I know it is not. Same pain when pressure put on it by bending, sitting in my truck against seats etc... Now I am worried. NEVEER had something like this other than a Gal Blagger which was removed.
Patient may have inadvertently been given 1cc of Moderna COVID vaccine instead of 0.5cc. Patient notified. State f MD notified
Pfizer Covid Vaccine First Shot at 945am on Sat. 04/10/21.  Woke up in middle of  Saturday night/Sunday morning on 04/11/21 at approx. 3am with very loud ringing and buzzing in both ears.  Have had loud ringing in ears since then.  Visited primary health care provide NP on 04/19/21 and was prescribed  6 day treatment course of Methyliprednisolone tablets, USP 4 mg, which I began on 04/20/21.   This treatment as of 04/24/21 has provided very little relief.   On two week anniversary (04/24/21) still have very loud ringing in ears.  Cannot sleep.  Cannot focus.  No appetite.
1/10 headache. Fever, chills, shaking 1/10-1/12. Urinary tract infection 1/11.
Arm is sore; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Arm is sore) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     NO medical history information was reported.     On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (Arm is sore). At the time of the report, VACCINATION SITE PAIN (Arm is sore) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant Concomitant medications were reported.   No Treatment information for the event was provided. This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 22-Feb-2021 and was forwarded to Moderna on 23-Feb-2021.    This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Arm is sore) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     NO medical history information was reported.     On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (Arm is sore). At the time of the report, VACCINATION SITE PAIN (Arm is sore) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant Concomitant medications were reported.   No Treatment information for the event was provided.
cold; cold sore; canker sore; This spontaneous case was reported by a patient and describes the occurrence of NASOPHARYNGITIS (cold), ORAL HERPES (cold sore) and APHTHOUS ULCER (canker sore) in a female patient of an unknown age who received SPIKEVAX NOS (SPIKEVAX NOS) for COVID-19 prophylaxis.     No Medical History information was reported.   On an unknown date, the patient received fifth dose of SPIKEVAX NOS (SPIKEVAX NOS) (unknown route) 1 dosage form. On an unknown date, received fourth dose of SPIKEVAX NOS (SPIKEVAX NOS) (unknown route) dosage was changed to 1 dosage form, third dose of SPIKEVAX NOS (SPIKEVAX NOS) (unknown route) dosage was changed to 1 dosage form, second dose of SPIKEVAX NOS (SPIKEVAX NOS) (unknown route) dosage was changed to 1 dosage form and first dose of SPIKEVAX NOS (SPIKEVAX NOS) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced NASOPHARYNGITIS (cold), ORAL HERPES (cold sore) and APHTHOUS ULCER (canker sore). At the time of the report, NASOPHARYNGITIS (cold), ORAL HERPES (cold sore) and APHTHOUS ULCER (canker sore) outcome was unknown.            No concomitant medication was reported. It was reported that patient had canker sore in her mouth and wanted to know if she can receive the new Spikevax 2023-2024 vaccine while she had this symptom. No treatment information was provided.   Reporter did not allow further contact
11/01/22 presents to EC ED for "shortness of breath". PMHx of "A. fib, mitral valve replacement on anticoagulation, CHF, CKD"
Follow-up information provided additional events, product details, lab results, medical history and patient demographics. This case was considered medically important. Information regarding Hib-Titer Vaccine was received from an attorney regarding a 4-year-old male patient who experienced pervasive developmental disorder, childhood disintegrative disorder, encephalopathy, neurological damage; neurological incapacity, neurodevelopmental disorder, speech disorder, developmental incapacity, mental incapacity; intellectual incapacity, cumulative toxic levels of mercury; mercury poisoning and learning disabilities, disorders, and impairments. The patient received the fourth dose on 04-Jan-1995. The patient also received the first dose of MMR II on 04-Jan-1995. On 04-Jan-1995, the patient received a fourth dose of Hib vaccine along with other childhood immunizations. In October of 1997, at the age of 4, patient was diagnosed with pervasive developmental disorder. On 16-Mar-2006, at the age of 6, patient was then diagnosed with childhood disintegrative disorder and on 17-Mar-2000, patient was also diagnosed with encephalopathy. On unspecified dated, the patient was also diagnosed with neurological damage; neurological incapacity, neurodevelopmental disorder, speech disorder, developmental incapacity, mental incapacity; intellectual incapacity, cumulative toxic levels of mercury; mercury poisoning and learning disabilities, disorders, and impairments. Blood lead (results: < mcg/dl) was done on 05-Nov-1999. Additionally, audiogram (results: no longstanding otologic disease process) was done on an unspecified date.
high pitched cry, fever 38.1 R, intermittent episodes of limb jerking over 1/2 hr by description felt to be seizure; On arrival @ med facility pt nl; no rx;
CLIENT BECAME LIGHT HEADED AND DIZZY-B/P- 125/83-P. 72  O2 98.  11: 20 126/ 77- 98P. 77 SAT.  11: 125/83  P. 73 SAT. 98